Analysis of von Hippel-Lindau hereditary cancer syndrome: implications of oxygen sensing.
Yang
Haifeng
H
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Ivan
Mircea
M
Min
Jung-Hyun
JH
Kim
William Y
WY
Kaelin
William G
WG
D026481:Blotting, Far-Western / Q000379:methods; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D013058:Mass Spectrometry; D010100:Oxygen / Q000378:metabolism*; D011393:Procollagen-Proline Dioxygenase / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D006623:von Hippel-Lindau Disease / Q000378:metabolism*
D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; D011393:Procollagen-Proline Dioxygenase; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D010100:Oxygen